Moreover, although many constructs have been designed for intratumoural activation, particularly intralysosomal drug release (using low pH or lysosomal enzymes such as cathepsin B) (Fig. 1), few tumour models are calibrated with respect to these activation mechanisms. The gene discussed is CTSB; the disease is neoplasm.